Mohamed ElSayed

Executive Director at Nucleic Acid Therapeutics Initiative (NATi)

Speaker

Dr. Mohamed ElSayed is the Executive Director of NATi, where he previously served as its inaugural Chief Scientific Officer. He brings over 25 years of leadership experience across the pharmaceutical, biotech, and academic sectors. Prior to NATi, he was the Executive Vice President and Chief Technology Officer at RVAC Medicines and formerly the Vice President of Biotechnology at Eli Lilly, where he led the development of oral biologics and mRNA platforms, advancing multiple assets from discovery to clinical proof-of-concept. He has also held senior roles at Abbvie, Samyang, and Guilford Pharmaceuticals, and was a tenured professor at the University of Michigan. Dr. ElSayed holds a Bachelor of Pharmacy from Cairo University and a Ph.D. in Pharmaceutical Sciences from the University of Maryland. He completed his postdoctoral research at the University of Washington with fellowships from the National Cancer Society and the Susan G. Komen Foundation.